Thanksgiving Deliciousness

From eNewsletter 11/3/2025

DID YOU KNOW that a new scientific statement on inflammation from the American College of Cardiology confirms the value of high-sensitivity C-reactive protein (hsCRP) in clinical decision-making by stressing the importance of universal screening of the biomarker in both primary and secondary prevention of cardiovascular disease?

The statement, published in the Journal of the American College of Cardiology, provides consensus recommendations for screening, evaluation, and risk assessment for cardiovascular disease; inflammatory biomarkers in cardiovascular imaging; inflammation inhibition in behavioral and lifestyle risks; and anti-inflammatory approaches in primary and secondary prevention, as well as in heart failure and other cardiovascular diseases.

This is great to see. Now tell your doctors to screen for it routinely like we have for 15 years!

To read the rest of today's issue, please go to this page.